CUMBERLAND PHARMACEUTICALS RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHSat, 04 Apr 2026 18:09:46 +0200https://images.finanzen.net/images/finanzen_net_neu.gifCUMBERLAND PHARMACEUTICALS RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netCumberland Pharmaceuticals öffnete die Bücher zum abgelaufenen QuartalFri, 06 Mar 2026 06:35:06 +0100https://www.finanzen.net/nachricht/aktien/cumberland-pharmaceuticals-oeffnete-die-buecher-zum-abgelaufenen-quartal-15538521Cumberland Pharmaceuticals hat am 03.03.2026 die Geschäftsergebnisse zum jüngsten Jahresviertel vorgestellt.Das Ergebnis je Aktie fiel negativ aus. Der Verlust je Papier wurde auf 0,09 USD beziffert. ...

]]>https://www.finanzen.net/nachricht/aktien/cumberland-pharmaceuticals-oeffnete-die-buecher-zum-abgelaufenen-quartal-15538521CALDOLOR® (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENTMon, 08 Dec 2025 15:05:00 +0100https://www.finanzen.net/nachricht/aktien/caldolor-ibuprofen-injection-cms-issued-j-code-now-associated-with-reimbursement-price-supporting-non-opioid-pain-management-15342775

NASHVILLE, Tenn., Dec. 8, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), ...

]]>https://www.finanzen.net/nachricht/aktien/caldolor-ibuprofen-injection-cms-issued-j-code-now-associated-with-reimbursement-price-supporting-non-opioid-pain-management-15342775Cumberland Pharmaceuticals: Was beim Unternehmen in den jüngsten Büchern stehtThu, 06 Nov 2025 06:35:06 +0100https://www.finanzen.net/nachricht/aktien/cumberland-pharmaceuticals-was-beim-unternehmen-in-den-juengsten-buechern-steht-15203532Cumberland Pharmaceuticals lud am 04.11.2025 zur turnusmäßigen Finanzkonferenz und hat dort das Zahlenwerk zum jüngsten Quartal veröffentlicht, das am 30.09.2025 endete.Cumberland Pharmaceuticals ...

]]>https://www.finanzen.net/nachricht/aktien/cumberland-pharmaceuticals-was-beim-unternehmen-in-den-juengsten-buechern-steht-15203532CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTHTue, 04 Nov 2025 23:00:00 +0100https://www.finanzen.net/nachricht/aktien/cumberland-pharmaceuticals-reports-12-year-to-date-revenue-growth-15189593

NASHVILLE, Tenn., Nov. 4, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), ...

]]>https://www.finanzen.net/nachricht/aktien/cumberland-pharmaceuticals-reports-12-year-to-date-revenue-growth-15189593CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATETue, 28 Oct 2025 21:05:00 +0100https://www.finanzen.net/nachricht/aktien/cumberland-pharmaceuticals-to-announce-q3-2025-financial-results-company-update-15134668

NASHVILLE, Tenn., Oct. 28, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), ...

]]>https://www.finanzen.net/nachricht/aktien/cumberland-pharmaceuticals-to-announce-q3-2025-financial-results-company-update-15134668CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIOMon, 20 Oct 2025 15:05:00 +0200https://www.finanzen.net/nachricht/aktien/cumberland-phamaceuticals-announces-the-addition-of-an-established-fda-approved-product-to-its-commercial-portfolio-15097186

 Cumberland to expand its gastroenterology offerings with the market-leading Helicobacter pylori therapy

NASHVILLE, ...

]]>https://www.finanzen.net/nachricht/aktien/cumberland-phamaceuticals-announces-the-addition-of-an-established-fda-approved-product-to-its-commercial-portfolio-15097186CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC.Mon, 13 Oct 2025 15:05:00 +0200https://www.finanzen.net/nachricht/aktien/cumberland-pharmaceuticals-vibativ-added-to-national-group-purchasing-agreement-with-premier-inc-15030038

Premier Membership includes 4,350 U.S. Hospitals

NASHVILLE, Tenn., ]]>https://www.finanzen.net/nachricht/aktien/cumberland-pharmaceuticals-vibativ-added-to-national-group-purchasing-agreement-with-premier-inc-15030038